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Abstract
In this paper, we present the global analysis of a HCV model under therapy.
We prove that the solutions with positive initial values are global, positive, bounded
and not display periodic orbits. In addition, we show that the model is globally
asymptotically stable, by using appropriate Lyapunov functions.
Keywords:HCV cellular model, differential system, therapy, local and global solution,
invariant set, stability.
1 Introduction
According to [15] recent estimates, more than 185 million people around the world have
been infected with the hepatitis C virus (HCV), of whom 350 000 die each year. One
third of those who become chronically infected are predicted to develop liver cirrhosis or
hepatocellular carcinoma. Despite the high prevalence of disease, most people infected
with the virus are unaware of their infection. For many who have been diagnosed, treat-
ment remains unavailable. Treatment is successful in the majority of persons treated, and
treatment success rates among patients treated in low- and middle-income countries are
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2 A. Nangue
similar to those in high-income countries Hepatitis C virus (HCV) infects liver cells (hep-
atocytes). Approximately 200 million people worldwide are persistently infected with the
HCV and are at risk of developing chronic liver disease, cirrhosis and hepatocellular car-
cinoma. HCV infection therefore represents a significants global public health problem.
HCV established chronic hepatitis in 60%-80% of infected adults [12].
In literature, several mathematical models have been introduced for understanding
HCV temporal dynamics [4, 9, 10].
In this article, we consider the basic extracellular model with therapy presented by
Neumann et al. in [9]. Given the recent surge in the development of new direct acting an-
tivirals agents for HCV therapy, mathematical modelling of viral kinetics under treatment
continues to play an instrumental role in improving our knowledge and understanding of
virus pathogenesis and in guiding drug development [2, 7, 11].
To proceed, we assume that the uninfected target cells are produced at a rate λ, die
at constant rate d per cell. On the other hand, the target cells are infected with de novo
infection rate constant of β and the infected cells die at a constant rate of δ per cell. The
hepatitis C virions are produced inside the infected cells at an average rate p per infected
cell and have a constant clearance rate c per virion. Thereby, viral persistence will occur
when rate of viral production (p), de novo infection (β), and production of target cells (λ)
exceeds the clearance rate (c), death rate of infected cells (δ) and target cells death rate
(d). In addition, the therapeutic effect of IFN treatment in this model involved blocking
virions production and reducing new infections which, are described in fractions (1 − ε)
and (1 − η), respectively. (0 ≤ ε ≤ 1, 0 ≤ η ≤ 1). According to [3, 9], the above
assumptions lead to the following differential equations :
dT
dt
= λ− dT − (1− η)βV T ; (1a)
dI
dt
= (1− η)βV T − δI; (1b)
dV
dt
= (1− ε)pI − cV ; (1c)
where the equations relate the dynamics relationship between, T as the uninfected target
cells (hepatocytes), I as the infected cells and V as the viral load (amount of viruses
present in the blood). In this article, model system (1) is taken as the original model used
to analyse the HCV dynamics.
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Figure 1: Schematic representation of the original viral kinetic model of HCV infection
under treatment. T represents the target uninfected cells, I is the infected cells and V
represents the free virus
The initial conditions associated to system (1) are given by :
T (t0) = T0, I(t0) = I0, V (t0) = V0, t0 ∈ [0,+∞[. (2)
This paper is organized as follows : The global properties of the solutions to the mathe-
matical model is carried out in Section 1. The stability of the disease non-infected steady
state, and the infected steady state is analysed in section 2.
2 Properties of solutions to the Cauchy problem (1),(2)
2.1 Existence of local solutions
The first step in examining model (1) is to prove that local solution to the initial-value
problem does, in fact, exist, and that this solution is unique.
Theorem 2.1 Let T0, I0, V0 ∈ R be given. There exists t1 > t0 > 0 and continuously
differentiable functions T , I , V : [0, t0) −→ R such that the ordered triple (T, I, V )
satisfies (1) and (T (t0), I(t0), V (t0)) = (T0, I0, V0).
Proof. To prove the result, we use the classical Cauchy-Lipschitz theorem. Since the first
order system of ordinary differential equations (1) is autonomous, it suffices to show that
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the function H : R3 −→ R3 defined by :
H(x) =
á
h1(x1, x2, x3)
h2(x1, x2, x3)
h3(x1, x2, x3)
ë
=
á
λ− dx1 − (1− η)βx3x1
(1− η)βx3x1 − δx2
(1− ε)px2 − cx3
ë
(3)
is locally Lipschitz in its x argument. In fact, it is enough to notice that the jacobian
matrix
∇H(x) =

−d− (1− η)βx3 0 −(1− η)βx1
(1− η)βx3 −δ (1− η)βx1
(1− ε)p 0 −c

is linear in x and therefore locally bounded for every x ∈ R3. Hence, H has a continuous,
bounded derivative on any compact subset of R3 and so H is locally Lipschitz in x; In
addition H is continuous. By Cauchy-Lipschitz theorem, there exits a unique solution,
x(t), to the ordinary differential equation
x′(t) = H(x(t))
with initial value x(t0) = x0 on [t0, t1] for some time t1 > t0 ≥ 0.
Remark 1 The model (1) can be rewrite in the form
S ′(t) = H(S(t))
where S(t) = (T (t), I(t), V (t))t and F is defined by (3).
Remark 2 Since H is a continuously differentiable function, we deduce a unique maximal
solution of initial value problem (1), (2). In addition, F, being indefinitely continuously
differentiable, we can also deduce that this solution is also only if indefinitely continuously
differentiable.
Additionally, we may show that for positive initial data, solutions of (1), (2) remain posi-
tive as long as they exist.
2.2 Positivity
Theorem 2.2 Let (T, I, V ) be a solution of the Cauchy problem (1), (2) on an interval
[t0, t1[. Assume the initial data of (1), (2) satisfy T0 > 0, I0 > 0, and V0 > 0 then T (t),
T (t) and V (t) remain positive for all t ∈ [t0, t1[.
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Proof. Call the variables xi. If there is an index i and a time t for which xi(t) = 0, let t∗
be the infimum of all such t for any i. Then the restriction of the solution to the interval
[t0; t∗[ is positive and xi(t∗) = 0 for a certain value of i. The equation for xi in the system
(1) can be written in the form :
dxi(t)
dt
= −xif(x) + g(x),
where g(x) is non-negative. As a consequence dxi(t)
dt
≥ −xif(x) and xi(t) > 0, ∀t ∈
[t0, t∗]. In fact :
Recall that all constants in the system (1) are non-negative. Using this and the solutions
on [t0, t∗[, we have :
dI
dt
= −Iδ + (1− η)βV T
dV
dt
= −V c+ (1− ε)pI ⇒

dI
dt
≥ −Iδ
dV
dt
≥ −V c ⇒

d
dt
(ln I(t)) ≥ −δ
d
dt
(lnV (t)) ≥ −c,
which yields :
I(t) ≥ I0e−δ(t−t0),
V (t) ≥ V0e−c(t−t0) for all t ∈ [t0, t∗] .
Similarly, in one hand we have :
dT
dt
= λ− dT − (1− η)βV T ≤ λ.
Solving for T yields
T (t) ≤ T0 + λ(t− t0) ≤ A1(1 + (t− t0))
where A1 ≥ max{T0, λ}. In other hand we have :
d
dt
(I + V ) = −Iδ + (1− η)βV T − V c+ (1− ε)pI ≤ βV T + pI.
Recall that we have a bound on T, so
d
dt
(I + V ) ≤ A1(1 + (t− t0))βT + pI
≤ A2(1 + (t− t0))(T + I)
where A2 ≥ max{A1β, p}. Solving the differential inequation yields :
I(t) + V (t) ≤ A3H1(t), ∀t ∈ [t0, t∗] (4)
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where A3 > 0 depends upon A2, I0 and V0 only, and H1(t) = e
∫ t
t0
(1+(t−t0))dτ
> 0,
t ∈ [t0, t∗]. Using the fact that I(t) and V (t) are positive, (4) yields :
A3H1(t) ≥ I(t) + V (t) ≥ V (t),
A3H1(t) ≥ I(t) + V (t) ≥ I(t).
With these bounds in place, we can now examine T (t) and bound it from below using :
dT
dt
= λ− dT − (1− η)βV T
≥ −dT − (1− η)βV T
≥ −dT − (1− η)βA3H1(t)T
dT
dt
≥ −A4(1 +H1(t))T
for t ∈ [t0, t∗], where A4 ≥ max{d, (1− η)βA3}. Shifting that last term to the other side
of the equation yields :
dT (t)
dt
+ A4(1 +H1(t))T (t) ≥ 0.
Since we know
d
dt
Ç
T (t) + e
A4
∫ t
t0
(1+H1(τ))dτ
å
≥ 0,
we find that for t ∈ [t0, t∗],
T (t) ≥ e−A4
∫ t
t0
(1+H1(τ))dτ
> 0
Therefore xi(t) > 0, for all t ∈ [t0, t∗]. In particular xi(t∗) > 0, which is a contradiction
and the theorem is proven.
Remark 3 (i) With this, we have a general idea that the model is sound, and can say
with certainty that it remains biologically valid as long as it began with biologically-
reasonable (i.e, positive) data. This also shows that once infected, it is entirely
possible that the virus may continue to exist beneath a detectable threshold without
doing any damage.
(ii) One reason why we choose the strict inequalities for the initial data is that often
in biological (or chemical) applications we are interested in the case of solutions
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where all unknowns are positive. This means intuitively that all elements of the
model are ’active’. On the other hand it is sometimes relevant to consider solu-
tions with non-strict inequalities. In fact the statement of the theorem with strict
inequalities implies the corresponding statement with non-strict inequalities in a
rather easy way.
2.3 Existence of global solutions
It will now be shown, with the help of the continuation criterion the existence of global
solutions.
Theorem 2.3 The solutions of the Cauchy problem (1), (2), with positive initial data,
exist globally in time in the future that is : on [t0,+∞[.
Proof. To prove this it is enough to show that all variables are bounded on an arbitrary
finite interval [t0; t). Using the positivity of the solutions is suffices to show that all
variables are bounded above.
Taking the sum of equations (1a) and (1b) shows that :
d
dt
(T + I) ≤ λ
and hence that T (t) + I(t) ≤ T0 + I0 +λ(t− t0). Thus T and I are bounded on any finite
interval. The third equation i.e. equation (1c), then shows that V (t) cannot grow faster
than linearly and is also bounded on any finite interval.
2.4 Global boundedness of solutions
Theorem 2.4 For any positive solution (T, I, V ) of system (1), (2) we have :
T (t) + I(t) ≤ C1 and V (t) ≤ C2
where
C1 = max
®
T0 + I0,
λ
min{d, δ}
´
, C2 = max
®
V0,
(1− ε)pC1
c
´
.
Proof. According to equations (1a) and (1b), we have :
d
dt
(T + I) = λ− dT − δI
≤ λ−min{d, δ}(T + I).
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Gronwall inequality[13] yields :
T + I ≤ (T (t0) + I(t0))e−min{d,δ}(t−t0) +
∫ t
t0
λe−
∫ t
u
−min{d,δ}drdu
≤ (T0 + I0)e−min{d,δ}(t−t0) + λ
∫ t
t0
e−min{d,δ}(t−u)du
≤ (T0 + I0)e−min{d,δ}(t−t0) + λe
−min{d,δ}(t−t) − e−min{d,δ}(t−t0)
min{d, δ}
≤ max
®
(T0 + I0),
λ
min{d, δ}
´
e−min{d,δ}(t−t0)
+ max
®
(T0 + I0),
λ
min d, δ
´
(1− e−min{d,δ}(t−t0))
≤ max
®
(T0 + I0),
λ
min{d, δ}
´ Ä
e−min{d,δ}(t−t0) + 1− e−min{d,δ}(t−t0)ä
T + I ≤ max
®
(T0 + I0),
λ
min{d, δ}
´
.
Another hand, from equation (1c), we have :
dV
dt
= (1− ε)pI − cV
≤ (1− ε)p(I + T )− cV
≤ (1− ε)pmax
®
(T0 + I0),
λ
min{d, δ}
´
− cV
≤ (1− ε)pC1 − cV.
Once more Gronwall inequality yields :
V (t) ≤ V (t0)e−c(t−t0) +
∫ t
t0
(1− ε)pC1e
∫ t
u
cdrdu
≤ V0e−c(t−t0) + (1− ε)pC1
∫ t
t0
e−c(t−u)du
≤ V0e−c(t−t0) + (1− ε)pC1 e
−c(t−t) − e−c(t−t0)
c
≤ V0e−c(t−t0) + (1− ε)pC11− e
−c(t−t0)
c
≤ max
®
V0,
(1− ε)pC1
c
´ Ä
e−c(t−t0) + 1− e−c(t−t0)ä
V (t) ≤ max
®
V0,
(1− ε)pC1
c
´
Therefore the theorem is proven.
As consequences of Theorem 2.4 we have :
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Remark 4 Let S be a solution of system (1). If S0 ∈ R × R3+ then, the limit of S(t)
exits when t −→ +∞ . In other words the solution is globally uniformly bounded in the
future. In particular, S is periodic if and only if S is stationary under the condition that
S(t) admits a finite limit when t tends to infinity.
Theorem 2.5 Let (t0, S0 = (T0, I0, V0)) ∈ R × R3+ and ([t0, T [, S = (T, I, V )) be a
maximal solution of the Cauchy problem (1), (2)(T ∈]t0,+∞[). If T (t0) + I(t0) ≤ C3
and V (t0) ≤ C4 then the set :
Ω =
¶
(T (t), I(t), V (t)) ∈ R3+ : T (t) + I(t) ≤ C3, V (t) ≤ C4
©
,
where C3 =
λ
min{d, δ} and C4 =
(1− ε)pλ
cmin{d, δ} , is a positively invariant set by system (1).
Proof. Let t1 ∈ [t0, T [. We shall show that :
(i) If T (t1) + I(t1) ≤ C3 then for all t1 ≤ t < T , T (t) + I(t) ≤ C3.
(ii) If V (t1) ≤ C4 then for all t1 ≤ t < T , V (t) ≤ C4.
(i) Let us suppose that there exists ε1 > 0 such that : t1 ≤ t1 + ε1 < T ,
(T + I)(t1 + ε1) > C3.
Let t∗1 = inf{t ≥ t1 / (T + I)(t) > C3}.
Since (T + I)(t∗1) = C3, hence
(T + I)(t) = C3 +
d
dt
(T (t∗1) + I(t
∗
1))(t − t∗1) + o(t − t∗1), t −→ t∗1. In addition,
according to equations (1a) and (1b) of system (1) we have :
d
dt
(T (t) + I(t)) = λ− dT − δI
which yields :
d
dt
(T + I)(t∗1) ≤ λ−min{d, δ}(T + I)(t∗1)
≤ λ−min{d, δ}C3
≤ λ−min{d, δ} λ
min{d, δ}
≤ 0,
hence, there exists ε˜ > 0 such that for all t∗1 ≤ t < t∗1 + ε˜, (T + I)(t) ≤ C3, a
contradiction. therefore for all t ∈ [t0, T [, (T + I)(t) ≤ C3.
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(ii) Let us suppose that there exists ε1 > 0 such that : t1 ≤ t1 + ε1 < T ,
V (t1 + ε1) > C4.
Let t∗1 = inf{t ≥ t1 / V (t) > C3}.
Since V (t∗1) = C3, hence
V (t) = C4 +
dV (t∗1)
dt
(t− t∗1) + o(t− t∗1), t −→ t∗1. In addition, according to equation
(1c) of system (1) we have :
dV (t)
dt
= (1− ε)pI − cV
which yields :
d
dt
V (t∗1) ≤ (1− ε)p(I + T )(t∗1)− cV (t∗1)
≤ (1− ε)pC3 − cC4
≤ (1− ε)p λ
min{d, δ} − c
(1− ε)pλ
cmin{d, δ}
d
dt
V (t∗1) ≤ 0,
hence, there exists ε˜ > 0 such that for all t∗1 ≤ t < t∗1 + ε˜, V (t) ≤ C4, a contradic-
tion. therefore for all t ∈ [t0, T [, V (t) ≤ C3.
3 Stability analyses
3.1 Equilibria, Basic reproduction number R0 and local stability
According to [3], apart from an infection-free equilibrium
E0 = (T 0, 0, 0) where T 0 =
λ
d
(5)
the system (1) has an infected equilibrium during therapy E∗ = (T ∗, I∗, V ∗), where :
T ∗ =
cδ
(1− η)β(1− ε)p, I
∗ =
(1− ε)(1− η)λpβ − dcδ
(1− η)(1− ε)pβδ
V ∗ =
(1− η)(1− ε)λpβ − dcδ
(1− η)δcβ =
p(1− ε)
c
I∗. (6)
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The basic reproduction number R0 has been defined in the introduction as the aver-
age number of secondary infections that occur when one infective is introduced into a
completely susceptible host population [5, 6, 14]. Note that R0 is also called the basic
reproduction ratio [5] or basic reproductive rate [1]. It is implicitly assumed that the in-
fected outsider is in the host population for the entire infectious period and mixes with the
host population in exactly the same way that a population native would mix. Following
the method done by [14], we have :
Proposition 3.1 The basic reproduction number R0 for model (1) is given by :
R0 = (1− η)(1− ε)λpβ
cdδ
.
Now we can express the components of infected equilibrium in term of R0. Hence (6)
becomes :
T ∗ =
1
R0
λ
d
, I∗ =
cd
(1− η)(1− ε)pβ (R0 − 1), V
∗ =
d
(1− η)(R0 − 1)β (7)
The following results summarize the main results regarding the local stability of the
disease-free steady state E0, and the local stability of the infected steady state during
therapy E∗. The proof of these results can be found in [3].
Theorem 3.2 The infection-free steady state E0 of model (1) is locally asymptotically
stable if R0 ≤ 1 and unstable if R0 > 1
Theorem 3.3 The infected steady state during the therapy E∗ of model (1) is locally
asymptotically stable if R0 > 1 and unstable if R0 > 1
3.2 Global Stability
In this section, firstly we prove the global stability of the infection-free equilibrium E0
of model (1) when the basic reproduction number is less than or equal to unity. And
secondly we prove the global stability of infected equilibrium E∗ whenever it exists. We
have seen previously[3] that the unique positive endemic equilibrium exits when the basic
reproduction number is greater than or equal to unity.
Theorem 3.4 (i) The infection-free steady state E0 of model (1) is globally asymptot-
ically stable if the basic reproduction number R0 ≤ 1 and unstable if R0 > 1.
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(ii) The infected steady state during therapy E∗ of model (1) is globally asymptotically
stable if the basic reproduction number R0 ≤ 1.
Proof.
(i) Consider the Lyapunov function :
L1(T, I, V ) = T − T 0 − T 0 ln T
T 0
+ I +
δ
(1− ε)pV.
L1 is defined, continuous and positive definite for all T > 0, I > 0, V > 0. Also,
the global minimum L1 = 0 occurs at the infection free equilibrium E0. Further,
function L1, along the solutions of system (1), satisfies :
dL1
dt
= λ− dT − T
0
T
λ+ dT 0 + (1− η)βV T 0 − cδ
(1− ε)pV.
Further collecting terms, we have
dL1
dt
= λ
Ç
2− T
T 0
− T
0
T
å
+ (R0 − 1) cδ
(1− ε)pV.
Since the arithmetical mean is greater than or equal to the geometrical mean,
√
a1a2 − (a1 + a2) ≤ 0, ai ≥ 0, i = 1, 2.
the function 2− T
T 0
− T 0
T
are non-positive for all T > 0. In addition, since R0 ≤ 1
ensures dL1
dt
≤ 0 for all T > 0, V > 0. The equality dL1
dt
= 0 holds only (a) at
the free equilibrium E0 or (b) when R0 = 1 and T = T 0. The latter case implies
I = V = 0.
Therefore, the largest compact invariant subset of the set
M = {(T, I, V ) ∈ Ω : dL1
dt
= 0}
is the singleton {E0}. By the Lasalle invariance principle[8], the infection-free
equilibrium is globally asymptotically stable if R0 ≤ 1. We have seen previously
that if R0 > 1, at least one of the eigenvalues of the Jacobian matrix evaluated at
E0 has a positive real part. Therefore, the infection-free equilibrium E0 is unstable
when R0 > 1.
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(ii) Consider the Lyapunov function :
L2(T, I, V ) = T−T ∗−T ∗ ln T
T ∗
+I−I∗−I∗ ln I
I∗
+
δ
(1− ε)p
Ç
V − V ∗ − V ∗ ln V
V ∗
å
.
The time derivative of L2 along the trajectories of system (1) is :
dL2
dt
=
dT
dt
− T
∗
T
dT
dt
+
dI
dt
− I
∗
I
dI
dt
+
δ
(1− ε)p
dV
dt
− δ
(1− ε)p
V ∗
V
dV
dt
.
Collecting terms, and canceling identical terms with opposite signs, yields
dL2
dt
= λ− dT − λT
∗
T
+ dT ∗ + (1− η)βV T ∗ − (1− η)βV T I
∗
I
+ δI∗
− cV δ
(1− ε)p − δ
V ∗
V
I +
cδ
(1− ε)pV
∗
= dR0T
∗ − dT ∗ T
T ∗
− dR0T ∗T
∗
T
+ dT ∗ + (1− η)βV ∗T ∗ V
V ∗
+ δI∗
−(1− η)βV ∗T ∗ T
T ∗
V
V ∗
I∗
I
− cδ
(1− ε)p
V
V ∗
V ∗ − δV
∗
V
I
I∗
I∗ +
cδ
(1− ε)pV
∗,
according to (7),
= dT ∗
Ç
R0 − T
T ∗
−R0T
∗
T
+ 1
å
+ (1− η)βV ∗T ∗
Ç
V
V ∗
− V TI
∗
V ∗T ∗I
å
+δI∗
Ç
2 +
V
V ∗
− V
∗I
V I∗
å
= dT ∗
Ç
R0 − T
T ∗
−R0T
∗
T
+ 1
å
+ δI∗
Ç
V
V ∗
− V TI
∗
V ∗T ∗I
å
+δI∗
Ç
2 +
V
V ∗
− V
∗I
V I∗
å
, since (1− η)βV ∗T ∗ = δI∗
dL2
dt
= dT ∗
Ç
R0 − T
T ∗
−R0T
∗
T
+ 1
å
+ δI∗
Ç
2− V
∗I
V I∗
− V TI
∗
V ∗T ∗I
å
+ δI∗
Ç
1− T
∗
T
å
−δI∗
Ç
1− T
∗
T
å
= dT ∗
Ç
R0 − T
T ∗
−R0T
∗
T
+ 1
å
+ δI∗
Ç
3− T
∗
T
− V
∗I
V I∗
− V TI
∗
V ∗T ∗I
å
−dT ∗(R0 − 1)
Ç
1− T
∗
T
å
, since δI∗ = dT ∗(R0 − 1),
dL2
dt
= dT ∗
Ç
2− T
T ∗
− T
∗
T
å
+ δI∗
Ç
3− T
∗
T
− V
∗I
V I∗
− V TI
∗
V ∗T ∗I
å
.
≤ 0.
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The terms between the brackets are less than or equal to zero by the inequality (the
geometric mean is less than or equal to the arithmetic mean)
3
√
a1a2a3 − (a1 + a2 + a3) ≤ 0, ai ≥ 0, i = 1, 2, 3.
It should be noted that dL2
dt
= 0 holds if and only if (T,X, V ) take the steady states
values (T ∗, X∗, V ∗) Therefore the infected equilibrium E∗ is globally asymptoti-
cally stable.
4 Numerical Simulation
Some numerical simulations have been done in the case R0 < 1 to confirm theoretical
result obtain on global stability for the uninfected equilibrium.
(a) solution curve for the un-
infected cells
(b) numerical solution curve
for the infected cells
(c) numerical solution curve
for the virus load
We run simulations using the initial conditions: T = 103, I = 2 and V = 1 and the
following parameter values : λ = 10; η = 1
10000000
; β = 2.4× 10−8; δ = 0.01; d = 0.001
; ε = 0.00000001; c = 0.9, p = 0.000000001.
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Figure 3: numerical simulation of the HCV model in 1000 days
5 Conclusion
In this paper, we have extended the first part of the work done by Chong et al. in [3] where
they only studied the local stability of the fundamental mathematical model of hepatitis C
infection with treatment.
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